| Literature DB >> 29288572 |
Stephen A Boppart1, J Quincy Brown2, Camile S Farah3, Esther Kho4, Laura Marcu5, Christobel M Saunders6, Henricus J C M Sterenborg4,7.
Abstract
The biannual International Conference on Biophotonics was recently held on April 30 to May 1, 2017, in Fremantle, Western Australia. This continuing conference series brought together key opinion leaders in biophotonics to present their latest results and, importantly, to participate in discussions on the future of the field and what opportunities exist when we collectively work together for using biophotonics for biological discovery and medical applications. One session in this conference, entitled "Tumor Margin Identification: Critiquing Technologies," challenged invited speakers and attendees to review and critique representative label-free optical imaging technologies and their application for intraoperative assessment and guidance in surgical oncology. We are pleased to share a summary in this outlook paper, with the intent to motivate more research inquiry and investigations, to challenge these and other optical imaging modalities to evaluate and improve performance, to spur translation and adoption, and ultimately, to improve the care and outcomes of patients. (2017) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE).Entities:
Keywords: cancer surgery; label-free; optical imaging; surgical margins
Mesh:
Year: 2017 PMID: 29288572 PMCID: PMC5747261 DOI: 10.1117/1.JBO.23.2.021104
Source DB: PubMed Journal: J Biomed Opt ISSN: 1083-3668 Impact factor: 3.170